Overall,data reported here show that CNBCA that lacks one of the butyric acidgroups of the parent compound functions with better potency in bothinhibiting SHP2 enzyme activity and suppressing breast cancer cellphenotypes. Here, PTPN11 is linked to breast carcinoma.